Informing Oral Nicotine Pouch Regulations to Promote Public Health
Part of paid clinical trials in Columbus, Ohio.
- Sponsor
- Ohio State University Comprehensive Cancer Center
- Study ID
- NCT06315881
- Phase
- PHASE2
- Status
- Recruiting
Conditions
- Tobacco-Related Carcinoma
Eligibility Criteria
- Sex
- ALL
- Age
- 21 Years - N/A
- Healthy Volunteers
- Not accepted
Interventions
- Biospecimen Collection — PROCEDUREUndergo blood sample and oral mucosa sample collection
- Cigarette — DRUGSmoke usual brand cigarette
- Nicotine Oral Pouch — DRUGInsert low FBN R/S ONP
- Nicotine Oral Pouch — DRUGInsert low FBN \> 99% S ONP
- Nicotine Oral Pouch — DRUGInsert high R/S ONP
- Nicotine Oral Pouch — DRUGInsert high FBN \> 99% ONP
- Smokeless Tobacco — DRUGInsert ST
- Survey Administration — OTHERAncillary studies
- Text Message-Based Navigation Intervention — OTHERReceive text with a link to daily diary surveys
Study Details
This clinical trial evaluates the characteristics of oral nicotine pouches (ONPs) to determine if they are a comparable substitute to cigarette or smokeless tobacco (ST) products. ONPs contain nicotine but no tobacco and are used primarily by adult tobacco uses in the United States (US). ONPs are recognized by the Food and Drug Administration as having lower risk than combustible cigarettes and are approved as a modified risk tobacco product. While ONPs have lower toxic risk than other tobacco products, acute and longer term harm related to their use has not been studied. Information gathered from this study may identify product characteristics of ONPs that improve successful switching from high-risk cigarettes or ST to lower risk ONPs.
Key Dates
- Start date
- Jan 13, 2025
- Status verified
- Apr 2026
- Primary completion
- Jan 31, 2028
- Completion
- Aug 31, 2028
Study Design
- Enrollment
- 160 participants (estimated)
- Allocation
- RANDOMIZED
- Intervention model
- PARALLEL
- Primary purpose
- PREVENTION
Arms
- Experimental: PHASE I ARM I (low FBN R/S ONP)Participants insert low free-base nicotine (FBN) R/S ONP product over 30 minutes and insert usual brand of ST over 30 minutes or smoke usual brand of cigarette over 5 minutes during each study visit for 5 visits over up to 3 months. Patients also undergo blood sample collection throughout study.
- Experimental: PHASE I ARM II (low FBN > 99% S ONP)Participants insert low FBN \> 99% S ONP product over 30 minutes and insert usual brand of ST over 30 minutes or smoke usual brand of cigarette over 5 minutes during each study visit for 5 visits over up to 3 months. Patients also undergo blood sample collection throughout study.
- Experimental: PHASE I ARM III (high FBN R/S ONP)Participants insert high R/S ONP product over 30 minutes and insert usual brand of ST over 30 minutes or smoke usual brand of cigarette over 5 minutes during each study visit for 5 visits over up to 3 months. Patients also undergo blood sample collection throughout study.
- Experimental: PHASE I ARM IV (high FBN > 99% ONP)Participants insert high FBN \> 99% S ONP product over 30 minutes and insert usual brand of ST over 30 minutes or smoke usual brand of cigarette over 5 minutes during each study visit for 5 visits over up to 3 months. Patients also undergo blood sample collection throughout study.
- Experimental: PHASE I ARM V (Usual brand ST or cigarette)Participants insert usual brand of ST over 30 minutes or smoke usual brand of cigarette over 5 minutes. Patients also undergo blood sample collection at 0, 5, 15, 30, 60, and 90 minutes.
- Experimental: PHASE II ARM I (low FBN R/S ONP)WASHOUT PERIOD: Participants use usual brand of ST or cigarettes for 1 week. CONTROL WEEK: Participants continue regular use of ST or cigarettes for 1 week and receive a text with a link to daily diary surveys to record tobacco use. Participants insert low FBN R/S ONP for 4 weeks. Participants also attend 2 study visits and undergo oral mucosa sample collection.
- Experimental: PHASE II ARM II (low FBN > 99% S ONP)WASHOUT PERIOD: Participants use usual brand of ST or cigarettes for 1 week. CONTROL WEEK: Participants continue regular use of ST or cigarettes for 1 week and receive a text with a link to daily diary surveys to record tobacco use. Participants insert to low FBN \> 99% S ONP product for 4 weeks. Participants also attend 2 study visits and undergo oral mucosa sample collection.
- Experimental: PHASE II ARM III (high R/S ONP)WASHOUT PERIOD: Participants use usual brand of ST or cigarettes for 1 week. CONTROL WEEK: Participants continue regular use of ST or cigarettes for 1 week and receive a text with a link to daily diary surveys to record tobacco use. Participants insert to high R/S ONP product for 4 weeks. Participants also attend 2 study visits and undergo oral mucosa sample collection.
- Experimental: PHASE II ARM IV (high FBN > 99% ONP)WASHOUT PERIOD: Participants use usual brand of ST or cigarettes for 1 week. CONTROL WEEK: Participants continue regular use of ST or cigarettes for 1 week and receive a text with a link to daily diary surveys to record tobacco use. Participants insert high FBN \> 99% S ONP product for 4 weeks. Participants also attend 2 study visits and undergo oral mucosa sample collection.
Primary Outcome Measure
Increased nicotine delivery [ Time Frame: Up to 3 months ]
Central Contacts
- The Ohio State University Comprehensive Cancer Center800-293-5066
Locations (1)
| Facility | City | State | ZIP | Site coordinators |
|---|---|---|---|---|
| Ohio State University Comprehensive Cancer Center | Columbus | Ohio | 43210 | Brittney L. Keller-Hamilton, PhD, MPH (PRINCIPAL_INVESTIGATOR) |
Find similar trials in Columbus, OH
Related Studies
- Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility StudyRecruiting · AIDS Malignancy Consortium · La Jolla, California
- Effects of Tobacco Cut and Nicotine Form on the Abuse Liability of Moist SnuffRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- Manipulating E-Cigarette Nicotine to Promote Public HealthRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio
- Studying the Health Perceptions and Social Behaviors of Graduate Students at the Ohio State University for the Development of Effective Oral Nicotine Pouch Addictive Risk CommunicationRecruiting · Ohio State University Comprehensive Cancer Center · Columbus, Ohio